The Pipeline Center

Filter Your Results




Gene Therapy for Retinal Diseases

The eye is an ideal target for gene therapy. It is relatively small and highly compartmentalized, and it is an immu…

Aron Shapiro

The DME Pipeline

It is well known that we are in the midst of a diabetes epidemic. In the past 30 years, the number of Americans diagno…

Peter K. Kaiser, MD

Object Identification with Artificial Vision

In this, a patient blinded by retinitis pigmentosa displays an ability to positively identify and differentiate between …

Word Identification Using Artificial Vision

A patient wearing the Alpha IMS artificial vision system (Retina Implant AG) correctly identifies white block letters ag…

The Preclinical Process: Drugs Designed for the Back of the …

For the past several years, Ora has worked with Retina Today to craft articles for a column titled “Clinical Tri…

Aron Shapiro; Andy Whitlock, PhD; and Claire Gelfman, PhD

Valved Trocars

Kirk H. Packo MD

The Clinical Utility of the Normative Database

A normative database calculates the average anatomic values, such as retinal thickness, of theoretically normal patients…

Ryan Bouchard and Peter K. Kaiser, MD

Applications for Neuroprotection: The Next Therapeutic Categ…

Pharmacologic agents used in retina medicine are highly advanced and help to address a variety of neovascular and inflam…

Pravin U. Dugel, MD


This Month's Supplements


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.